Webinar: Winning in the ADC Era

The ADC market isn’t just growing. It’s growing more complex.

With more antibody-drug conjugates approved and in development, often targeting the same tumors and patient populations, proving efficacy is no longer enough to stand out. Payers, prescribers, and guideline committees are asking harder questions: Which line of therapy? For which patient? Compared with what alternative? And based on what evidence?

Do you have the evidence to win the ADC treatment decision?

Join SALESEER for a webinar on how the next phase of ADC competition will be decided. We’ll explore:

• Why the strategic question has moved from “Does our ADC work?” to “Where does it fit, and why?”
• What kinds of evidence clarify sequencing, patient selection, and comparative value
• How to find the gaps in your evidence before competitors or payers do
• How to build evidence strategies that support real-world treatment decisions

WEBINAR DETAILS

Thursday, November 5th, 2026 | 10 AM CT | 11 AM ET | 8 AM PT | ZOOM